Lv2
118 积分 2023-10-31 加入
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
8小时前
待确认
Achievement rate of target blood pressure in patients with hypertension treated by hypertension specialists and non-specialists in a real-world setting
1天前
已完结
Early onset of hypertension and increased relative risks of chronic kidney disease and mortality: two population-based cohort studies in United Kingdom and Hong Kong
1天前
已完结
Hypertension management in patients with advanced chronic kidney disease with and without dialysis
1天前
已完结
Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies
10天前
已完结
Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates
14天前
已完结
Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy
1个月前
已完结
RN026: A lipoprotein(a) targeting siRNA with superior efficacy, extended duration and excellent safety profiles
4个月前
已关闭
Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendations
4个月前
已完结
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
5个月前
已完结
皖公网安备34019202002308
